Both in Biotechnology
ADMA Biologics vs Maze Therapeutics
Over the past year ADMA returned −26.3% and MAZE returned −4.3%; their daily moves had a correlation of 0.36.
ADMA −26.3% MAZE −4.3%Growth of $1, one year, split-adjusted
| Metric | ADMA | MAZE |
|---|---|---|
| Price | $11.41 | $31.48 |
| Market cap | $2.56B | $1.75B |
| Today | −2.89% | −1.41% |
| 1 month | +14.9% | +18.1% |
| 6 months | +8.5% | +15.9% |
| Year to date | −37.4% | −24.0% |
| 1 year | −26.5% | +0.7% |
| Revenue growth (YoY) | +2.0% | — |
| Gross margin | 69.4% | — |
| Net margin | 30.4% | — |
| P/E (TTM) | 15.1× | — |
| Price / sales | 5.0× | 87.4× |
| Net cash | -$60.6M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | 38.2% | 66.7% |
| Short % of float | 9.1% | 18.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).